Stay updated with breaking news from Sciences Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced today that it will present 15...
Shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) have received an average rating of “Moderate Buy” from the seventeen brokerages that are presently covering the firm, MarketBeat reports. Four analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1-year target price among […]
Dublin, May 23, 2023 (GLOBE NEWSWIRE) -- The "Companion Diagnostics: Technologies and Markets" report has been added to ResearchAndMarkets.com's...
StockNews.com started coverage on shares of Exact Sciences (NASDAQ:EXAS – Get Rating) in a research report sent to investors on Thursday morning. The brokerage issued a hold rating on the medical research company’s stock. Several other analysts have also recently issued reports on EXAS. Cowen upped their price target on shares of Exact Sciences from […]
Jupiter Asset Management Ltd. boosted its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 26.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 26,202 shares of the medical research company’s stock after buying an additional 5,435 shares during the quarter. […]